Zenas BioPharma, Inc. Proceeds from Issuance of Secured Debt
Zenas BioPharma, Inc. (ZBIO) reported Proceeds from Issuance of Secured Debt of $73.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSecuredDebt · last filed 2026-08-13
- Zenas BioPharma, Inc. proceeds from issuance of secured debt for the quarter ending 2026-06-30 was $0.00.
- Zenas BioPharma, Inc. proceeds from issuance of secured debt for the quarter ending 2026-03-31 was $73.50M.
| Period end | Proceeds from Issuance of Secured Debt 3 month | Proceeds from Issuance of Secured Debt 6 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $73.50M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $73.50M 10-Q · filed 2026-05-13 |